Blood Centers Complement Hospitals to Drive Cell and Gene Therapy Access

Blood centers are neutral partners, as they do not compete with hospitals for patients. Instead, they complement hospitals by providing a focused array of high-quality, specialized, patient-centric services, allowing hospitals to maintain primary relationships with patients and their families. The post Blood Centers Complement Hospitals to Drive Cell and Gene Therapy Access appeared first on…

Read More

Montana’s Medicaid Expansion Conundrum

HELENA, Mont. — Despite concerns about what Congress and the Trump administration might have planned for Medicaid, Montana’s Republican-led legislature and GOP governor appear ready to keep the state’s Medicaid expansion program in place beyond its scheduled end date this summer. State lawmakers don’t have the luxury of waiting until the federal picture sharpens. They…

Read More

Battle Royale: Small molecules vs. biologics

The Inflation Reduction Act (IRA) allows the Centers for Medicare and Medicaid Services to negotiate drug prices. However, CMS can only negotiated drug prices 9 years after drug approval for small molecules and 13 years after approval for large molecules. Why the difference? Do biologic treatments produce superior health benefits for patients? This is the…

Read More

Patients Are NPCs

By KIM BELLARD I found a new way to think about patients in an opinion piece by Ezra Klein: they’re NPCs. For those of you unfamiliar with gaming, NPCs are those characters in video games that aren’t controlled by live players; they’re part of the game, serving as background for the actions the actual players…

Read More